Advertisement

Topics

FDA outlines plan to speed rare disease drug designation

08:16 EDT 29 Jun 2017 | Reuters

WASHINGTON (Reuters) - The U.S. Food and Drug Administration plans to reorganize its drug review staff and create a SWAT team to eliminate a backlog of requests for rare disease drug designation, it said on Thursday.

Original Article: FDA outlines plan to speed rare disease drug designation

NEXT ARTICLE

More From BioPortfolio on "FDA outlines plan to speed rare disease drug designation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...